Figure 1From: Baseline staging tests based on molecular subtype is necessary for newly diagnosed breast cancerFrequency and distribution pattern of detectable metastatic diseases in bone, lung, and liver based on (A) clinical, (B) cT, (C) cN staging or (D) molecular subtypes. * P < 0.05, ** P < 0.01, *** P < 0.001.Back to article page